Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Prostaglandin E2 EP2 receptor (EP2) is a G protein-coupled receptor (GPCR) that binds prostaglandin E2 (PGE₂), a lipid mediator involved in numerous physiological and pathological processes. It primarily couples to Gs proteins, leading to increased cAMP levels and PKA activation. EP2 mediates diverse biological effects, including smooth muscle relaxation, immune modulation, and neuroprotection. It is implicated in cancer progression and is considered a potential drug target for both agonists and antagonists.
Gs protein activation, increased cAMP levels, PKA activation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prostaglandin E2 EP2 Receptor (EP2).